NEWARK, DE—The global keloid treatment market is projected to grow from USD 4,292.2 million in 2026 to USD 6,202.8 million by 2036, reflecting a steady CAGR of 3.8%. This expansion is driven by increasing clinical recognition of keloid scarring as a distinct fibrotic condition and the shift toward multi-modal management approaches that integrate laser therapy, pharmacological...